[1]Global Tuberculosis Control Report 2009.Available from: URL:http://www.who.int/tb/publications/global_report/2009/pdf/full_report.pdf [R]. Accessed April 4, 2009.[2] Gupta UD,Katoch VM. Animal models of tuberculosis [J]. Tuberculosis, 2005,85(5-6):277-293.[3] Ann M Ginsberg, Melvin Spigelman.Challenges in tuberculosis drug research and development [J]. Nature Medicine,2007,13(3):290-294.[4] Eric Nuermberger. Using Animal Models to Develop New Treatments for Tuberculosis. Semin Respir Crit Care Med, 2008,29(5):542-551.[5] 华树成,李丹,杨明.应用自动雾化吸入感染装置建立肺结核实验动物模型[J]. 吉林大学学报, 2008,34(1):1096-1098.[6] Kelly BP, Furney SK,Jessen MT, Orme IM. Low-dose aerosol infection model for testing drugs for efficacy againstMycobacterium tuberculosis [J]. Antimicrob Agents Chemother,1996,40(2):2809-2812.[7] Jayaram R,Gaonkar S, Kaur P, Suresh BL, Mahesh BN, Jayashree R, Nandi V, Bharat S, Shandil RK, Kantharaj E, Balasubramanian V. Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis[J]. Antimicrob Agents Chemother, 2003,47(7):2118-2124.[8] Dormans J, Burger M, Aguilar D, Hernandez-Pando R, Kremer K, Roholl P, Arend SM, Van Soolingen D. Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with differentMycobacterium tuberculosisgenotypes in a BALB/c mouse model [J]. Clin Exp Immunol, 2004,137(3):460-468.[9] 陆宇,王彬,郑梅琴,赵伟杰,李 NB67A . 应用Alamar Blue和MTT测定抗结核药物最低抑菌浓度的研究[J]. 中国防痨杂志,2007,29(3):499-501. [10]Dharmadhikari AS,Nardell EA. What Animal Models Teach Humans about Tuberculosis [J]. Am J Respir CellMol Bio,2008,39(5):503-508.[11] 陆宇,郑梅琴,王彬,赵伟杰,李 NB67A ,初乃惠,梁博文.氯法齐明抗结核分枝杆菌的体内外活性研究[J].中华结核和呼吸杂志,2008,31(10):752-755. |